| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8b919a09598a02c07e8429b1441b76e1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate |
1970-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1973-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2893a2e35eff60a4cabcbd6ff447fc76 |
| publicationDate |
1973-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3714365-A |
| titleOfInvention |
Reducing abnormally high plasma lipid levels in mammals with phenols |
| abstract |
PLASMA LEVELS ARE REDUCED BY INTERNALLY ADMINISTERING A PHENOL HAVING A NITROGEN-CONTAINING GROUP BONDED TO THE PHENOLIC NUCLEUS. A TYPICAL NITROGEN-CONTAINING GROUP IS EXEMPLARY PHENOLS ARE 2,6-DI-TERT-BUTYL-A-DIMETYLAMINOP-CRESOL AND A,A''-(METHYLININO)BIS(2,6 - DI-TERT-BUTYL-PCRESOL). TRINUCLEAR PHENOLS ARE ALSO DISCLOSED AS ARE SALTS SUCH AS HYDROCHLORIDES. -CH2-N(-R)-R'' |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0476846-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0476846-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0722723-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0722723-A3 |
| priorityDate |
1970-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |